Professor Brendan Crabb, Professor Lars Hviid (visiting from the Centre for Medical Parasitology at the Copengagen University Hospital in February) and Dr James Beeson.
With the ‘McKeon Review’ focusing on the future of medical research in Australia Burnet Institute Director and CEO, Professor Brendan Crabb highlights the need to build research capacity in malaria endemic countries.
Professor Crabb joined Burnet’s Head of the Centre for Immunology, Professor James Beeson to write the perspective in the most recent issue of high profile journal, Nature.
Professor Crabb and Professor Beeson joined eight other world leading experts looking at the ‘known unknowns’ in malaria research and what needs to be done to move forward.
“To help achieve these goals (in malaria research), government and private funding agencies must build research capacity in malaria-endemic countries, which will help promote greater linkages between immunology research, population studies and clinical trials.
Understanding the basis of human immunity will be key to developing long-lasting malaria vaccines, and will also enable us to identify populations at highest risk and to monitor those populations in malaria elimination programmes over time.”
CLICK HERE to read this and eight more perspectives on the ‘known unknowns’ in malaria research.
‘The McKeon Review’ is chaired by 2011 Australian of the Year, Simon McKeon, and aims to consult widely before recommending a 10-year strategic health and medical research plan for Australia.
For more information on the McKeon Review Public Forum on 1 May, head to the Burnet Institute website’s Events section.